Shine-On BioMedical Co (ROCO:6926) Total Liabilities : NT$42.21 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shine-On BioMedical Co Total Liabilities?

Shine-On BioMedical Co's Total Liabilities for the quarter that ended in Dec. 2024 was NT$42.21 Mil.

Shine-On BioMedical Co's quarterly Total Liabilities declined from Dec. 2023 (NT$23.26 Mil) to Jun. 2024 (NT$21.76 Mil) but then increased from Jun. 2024 (NT$21.76 Mil) to Dec. 2024 (NT$42.21 Mil).

Shine-On BioMedical Co's annual Total Liabilities increased from Dec. 2022 (NT$4.14 Mil) to Dec. 2023 (NT$23.26 Mil) and increased from Dec. 2023 (NT$23.26 Mil) to Dec. 2024 (NT$42.21 Mil).

Shine-On BioMedical Co Total Liabilities Historical Data

The historical data trend for Shine-On BioMedical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shine-On BioMedical Co Total Liabilities Chart

Shine-On BioMedical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

4.26

4.14

23.26

42.21

Shine-On BioMedical Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial					4.14	3.76	23.26	21.76	42.21

Shine-On BioMedical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shine-On BioMedical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	40.597	+	(1.356	+	0.257
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	42.21

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	1059.777	-	1017.567
	=	42.21

Shine-On BioMedical Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	40.597	+	(1.356	+	0.257
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	42.21

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	1059.777	-	1017.567
	=	42.21

Shine-On BioMedical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shine-On BioMedical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shine-On BioMedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 633, Section 2, Taiwan Avenue, Unit 6, 5th Floor, Xitun District, Taichung, TWN

Website

https://www.shineon-bio.com

Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.

Shine-On BioMedical Co Headlines

No Headlines